{
  "id": 14132165,
  "title": "Zydus, Formycon Get USFDA Review Acceptance For Keytruda Biosimilar FYB206",
  "url": "https://urgent.news/2026/10/13/zydus-formycon-get-usfda-review-acceptance-for-keytruda-biosimilar",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-13T04:55:53.000Z",
  "source": {
    "name": "Free Press Journal",
    "slug": "free-press-journal",
    "url": "https://www.freepressjournal.in/business/zydus-formycon-get-usfda-review-acceptance-for-keytruda-biosimilar-fyb206"
  },
  "original_language": "en",
  "account": null,
  "summary": "Mumbai: Zydus Lifesciences and Formycon AG jointly announced on Monday, 13 October 2026, that the US Food and Drug Administration (USFDA) has accepted for review the Biologics License Application (BLA) for FYB206. FYB206 is a proposed biosimilar to Keytruda (pembrolizumab). Regulatory Acceptance This acceptance marks the first publicly announced USFDA review of an application for a Keytruda…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}